FDA
The article provides a general overview of the existing regulatory framework associated with adverse events.
FDA
The article provides a general overview of the existing regulatory framework associated with adverse events.
FDA
The article describes in detail the approach to be applied with respect to clinical performance testing considerations including, inter alia, the ones associated with treatment parameters and protocols, safety and effectiveness endpoints and data, as well as adverse events
FDA
The new article highlights the aspects related to non-clinical testing considerations related to the devices covered by the scope of the guidance.
FDA
The article provides an overview of the new regulation and highlights the key points associated thereto.
#WednesdayWebinar Join us for our upcoming webinar Global Regulatory Changes to Expect in 2025 January 22, 2025 at 10 AM ET
Register Now
